{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:41:58Z","timestamp":1784522518721,"version":"3.55.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>The impact of a focused inpatient educational intervention on rates of medication-assisted therapy (MAT) for veterans with opioid use disorder (OUD) was evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective cohort analysis compared rates of MAT, along with rates of OUD-related emergency department (ED) visits and\/or hospital admission within 1 year, between veterans with a diagnosis of OUD who completed inpatient rehabilitation prior to implementation of a series of group sessions designed to engage intrinsic motivation to change behavior surrounding opioid abuse and provide education about MAT (the control group) and those who completed rehabilitation after implementation of the education program (the intervention group). A post hoc, multivariate analysis was performed to evaluate possible predictors of MAT use and ED and\/or hospital readmission, including completion of the opioid series, gender, age (&amp;gt;45 years), race, and specific prior substance(s) of abuse.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>One hundred fifty-eight patients were included: 95 in the control group and 63 in the intervention group. Rates of MAT were 25% (24 of 95 veterans) and 75% (47 of 63 veterans) in control and intervention groups, respectively (P &amp;lt; 0.01). Gender, completion of the opioid series, prior heroin use, and marijuana use met prespecified significance criteria for inclusion in multivariate regression modeling of association with MAT utilization, with participation in the opioid series (odds ratio [OR], 9.56; 95% confidence interval [CI], 4.36-20.96) and prior heroin use (OR, 3.26; 95% CI, 1.18-9.01) found to be significant predictors of MAT utilization on multivariate analysis. Opioid series participation and MAT use were independently associated with decreased rates of OUD-related ED visits and\/or hospital admission (hazard ratios of 0.16 [95% CI, 0.06-0.44] and 0.32 [95% CI, 0.14-0.77], respectively) within 1 year after rehabilitation completion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Focused OUD-related education in a substance abuse program for veterans with OUD increased rates of MAT and was associated with a decrease in OUD-related ED visits and\/or hospital admission within 1 year.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaa386","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T21:38:49Z","timestamp":1607549929000},"page":"301-309","source":"Crossref","is-referenced-by-count":5,"title":["Assessment of the impact of an opioid-specific education series on rates of medication-assisted treatment for opioid use disorder in veterans"],"prefix":"10.1093","volume":"78","author":[{"given":"Taylor","family":"Kirby","sequence":"first","affiliation":[{"name":"Phoenix VA Health Care System, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Connell","sequence":"additional","affiliation":[{"name":"VA St. Louis Health Care System, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Linneman","sequence":"additional","affiliation":[{"name":"VA St. Louis Health Care System, St. Louis, MO, USA"},{"name":"Saint Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,8]]},"reference":[{"key":"2021020809052553200_CIT0001","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"2021020809052553200_CIT0002","author":"US Department of Health and Human Services","year":"2017"},{"key":"2021020809052553200_CIT0003","author":"Substance Abuse Center for Behavioral Health Statistics and Quality","year":"2017"},{"key":"2021020809052553200_CIT0004","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J Addict Med."},{"key":"2021020809052553200_CIT0005","volume-title":"VA\/DoD Clinical Practice Guideline for the Management of Substance Use Disorders. Version 3.0","author":"Management of Substance Use Disorders Work Group","year":"2015"},{"key":"2021020809052553200_CIT0006","first-page":"S235","article-title":"Cost and utilization outcomes of opioid-dependence treatments","volume":"17","author":"Baser","year":"2011","journal-title":"Am J Manag Care."},{"key":"2021020809052553200_CIT0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","volume":"105","author":"Degenhardt","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"2021020809052553200_CIT0008","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatr Serv."},{"key":"2021020809052553200_CIT0009","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1360-0443.2007.02090.x","article-title":"Exposure to opioid maintenance treatment reduces long-term mortality","volume":"103","author":"Gibson","year":"2008","journal-title":"Addiction"},{"key":"2021020809052553200_CIT0010","first-page":"84","article-title":"Clinical and cost outcomes of buprenorphine treatment in a commercial benefit plan population","volume":"10","author":"Kissel","year":"2018","journal-title":"Am J Pharm Benefits"},{"key":"2021020809052553200_CIT0011","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"key":"2021020809052553200_CIT0012","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"2021020809052553200_CIT0013","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2004","journal-title":"Cochrane Database Syst Rev."},{"key":"2021020809052553200_CIT0014","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ."},{"key":"2021020809052553200_CIT0015","first-page":"179","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry","author":"Dutra","year":"2008"},{"key":"2021020809052553200_CIT0016","volume-title":"Enhancing motivation for change in substance use disorder treatment. Treatment Improvement Protocol (TIP) Series No. 35","author":"Substance Abuse and Mental Health Services Administration","year":"2019"},{"key":"2021020809052553200_CIT0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/ADM.0b013e3181d41ddb","article-title":"Adoption and implementation of medication in addiction treatment programs","volume":"5","author":"Kundsen","year":"2011","journal-title":"J Addict Med."},{"key":"2021020809052553200_CIT0018","volume-title":"Cognitive Behavioral Therapy for Substance Use Disorders Among Veterans: Therapist Manual.","author":"DeMarce","year":"2014"},{"key":"2021020809052553200_CIT0019","volume-title":"Cognitive Behavioral Therapy for Chronic Pain Among Veterans: Therapist Manual","author":"Murphy"},{"key":"2021020809052553200_CIT0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00005650-199406000-00001","article-title":"Determinants of readmission following inpatient substance abuse treatment: a national study of VA programs","volume":"32","author":"Peterson","year":"1994","journal-title":"Med Care"},{"issue":"2S","key":"2021020809052553200_CIT0021","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/j.japh.2017.01.022","article-title":"Opioid overdose education and naloxone distribution: development of the Veterans Health Administration\u2019s national program","volume":"57","author":"Oliva","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2021020809052553200_CIT0022","author":"National Institute on Drug Abuse","year":"2019"},{"key":"2021020809052553200_CIT0023","author":"National Institute on Drug Abuse","year":"2019"},{"key":"2021020809052553200_CIT0024","author":"National Institute on Drug Abuse","year":"2019"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/4\/301\/36212518\/zxaa386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/4\/301\/36212518\/zxaa386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T19:43:18Z","timestamp":1612813398000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/78\/4\/301\/6026351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12,8]]},"published-print":{"date-parts":[[2021,2,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaa386","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,15]]},"published":{"date-parts":[[2020,12,8]]}}}